31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
A California federal court has given employers a New Year’s gift, issuing a temporary restraining o...
Read More >
What constitutes sexual harassment? Portuguese law foresees two types of harassment: 1. Sexual har...
Read More >
In a press release this afternoon, Acting Chairman Ann Marie Buerkle announced that she would be wit...
Read More >
In my 27 years of practicing labor and employment law, I have observed a number of repeated preconce...
Read More >
A recent Court of Appeal decision highlights the importance of ensuring that a notice of claim in re...
Read More >
When an inspector from the Occupational Safety and Health Administration (OSHA) shows up at your wor...
Read More >